CARLSBAD, Calif., Oct. 15, 2013 /PRNewswire/ -- Patriot
Scientific Corporation (OTCBB: PTSC) today announced it has filed
its Report on Form 10-Q with the U.S. Securities and Exchange
Commission for the quarterly period ended August 31, 2013. The Report can be found on
the SEC's website at http://www.sec.gov/cgi-bin/browse-edgar.
Earlier this month Patriot announced that it had won its patent
infringement lawsuit against HTC Corporation. In litigation
before the United States District Court for the Northern District
of California, HTC was found to
infringe multiple claims within Patriot's US 5,809,336
patent. The '336 patent is one of several patents that are
part of a larger portfolio held by Patriot, known as the Moore
Microprocessor Patent (MMP) portfolio™.
In addition to Patriot's success against HTC in U.S. District
Court, the MMP portfolio has survived 17 re-examination challenges
before the USPTO. "We look forward to these clear validations
of the MMP portfolio to have now paved the way for future licensing
activity and operating returns commensurate with the portfolio's
broad applicability in the digital marketplace", stated
Cliff Flowers, Patriot's Interim
Chief Executive Officer.
About Patriot Scientific Corporation
Headquartered in Carlsbad,
California, Patriot Scientific Corporation is the co-owner
of the Moore Microprocessor Patent Portfolio™. For more
information on PTSC, visit www.ptsc.com.
About the MMP Portfolio™
The MMP Portfolio includes US patents as well as their European
and Japanese counterparts, which cover techniques that enable
higher performance and lower cost designs essential to consumer and
commercial digital systems ranging from PCs, cell phones and
portable music players to communications infrastructure, medical
equipment and automobiles.
Safe Harbor Statement: Statements herein which are not purely
historical, including statements regarding Patriot Scientific
Corporation's intentions, hopes, beliefs, expectations,
representations, projections, plans or predictions of the future
are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The forward-looking
statements involve risks and uncertainties including, but not
limited to, the risk that the recently filed actions and litigation
strategy may not be successful and the risks and uncertainties
relating to the future of our MMP joint-venture. It is
important to note that the company's actual results could differ
materially from those in any such forward-looking statements.
Factors that could cause actual results to differ materially
include, but are not limited to, risks and uncertainties associated
with the effect of changing economic conditions, trends in the
products markets, variations in the company's cash flow, market
acceptance risks, patent litigation, technical development risks,
and seasonality. Our business could be affected by a number
of other factors, including the risk factors listed from time to
time in the company's SEC reports including, but not limited to,
the annual report on Form 10-K for the year ended May 31, 2013 and the quarterly report on Form
10-Q for the period ended August 31,
2013. The company cautions investors not to place undue
reliance on the forward-looking statements contained herein.
Patriot Scientific Corporation disclaims any obligation, and does
not undertake to update or revise any forward-looking statements
made herein.
Contact:
Patriot Investor Relations
ir@ptsc.com
760-547-2700 x-102
SOURCE Patriot Scientific Corporation